NASDAQ
AEHR
Last Price
US $84.43
KEY FIGURES
MKT CAP
$2.9B
EPS
TTM
$-0.37
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
48.97x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Aehr Test Systems cash flow to debt ratio of -68.33% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Aehr Test Systems's free cash flow has decreased -1.33K% from $1.01M last year to $-12.39M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Aehr Test Systems's debt to equity ratio is 0.07, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Aehr Test Systems's debt has increased relative to shareholder equity from 0.06 last year to 0.07 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Aehr Test Systems has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Aehr Test Systems earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Aehr Test Systems's profit margin has decreased (-150.38%) in the last year from 50.07% to -25.23%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Aehr Test Systems's short-term assets of $88.78M exceed its short-term liabilities of $15.64M
Decreasing performance - ROA.
Aehr Test Systems's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Aehr Test Systems's return on equity of -8.87%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Aehr Test Systems's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Aehr Test Systems had positive net income in 3.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Aehr Test Systems has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Aehr Test Systems has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Aehr Test Systems's yearly earnings has decreased -111.79% since last year from $33.16M to $-3.91M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Aehr Test Systems's yearly revenue has decreased -10.95% since last year from $66.22M to $58.97M, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -8.33% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Aehr Test Systems's 3-year revenue CAGR of 5.08% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Aehr Test Systems had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Aehr Test Systems had positive ROE in 3.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Aehr Test Systems has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Aehr Test Systems has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Aehr Test Systems is overvalued relative to its fair value price of 0.26 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Aehr Test Systems has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Aehr Test Systems has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Aehr Test Systems has a price-to-book ratio of 20.30x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
Aehr Test Systems has a price-to-sales ratio of 63.81x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-8.87%
Return on equity
ROIC: -8.33%
Valuation History
-243.7X
Price to Earnings
EV/EBITDA: -246.5X
Cash flow
Profit margin
21.48%
(FY vs FY)
EBITDA Y/Y
21.41%
(FY vs FY)
Cash flow Y/Y
-29.31%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $84.43
—
Default assumptions
EBITDA Multiple
Fair Value
Market $84.43
-99.69%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.